1OGS | Hydrolase | date | May 13, 2003 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Acid-Beta-Glucosidase | ||||||||||||||
authors | H.Dvir, M.Harel, A.A.Mccarthy, L.Toker, I.Silman, A.H.Futerman, J.L.Sussman | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Glucosylceramidase Synonym: Glucocerebrosidase, Beta-Glucocerebrosidase, Acid Beta-Glucosidase, D-Glucosyl-N-Acylsphingosine Glucohydrolase, Alglucerase, Imiglucerase; Chain: A, B Ec: 3.2.1.45 Engineered: Yes |
Synthetic: Yes Organism_scientific: Homo Sapiens Organism_common: Human Expression_system: Chinese Hamster Ovary Cells Expression_system_cell_line: Cho | ||||||||||||||
symmetry | Space Group: C 2 2 21 | R_factor | 0.195 | ||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.0 Å | ||||||||||||
ligand | SO4, NDG, NAG | enzyme | Hydrolase E.C.3.2.1.45 | ||||||||||||
similarity | Belongs to family 30 of glycosyl hydrolases.[Glyco_hydro_30] | ||||||||||||||
catalytic activ. | D-glucosyl-n-acylsphingosine + h(2)o = d- glucose + n-acylsphingosine. | ||||||||||||||
subcellular loc. | Lysosomal, membrane bound. | ||||||||||||||
genes | GBA, GC (H. sapiens) | ||||||||||||||
Gene Ontology | chain A: GO:0004348, GO:0005764, GO:0005975, GO:0006665, GO:0007040, GO:0016020, GO:0016787, GO:0016798 chain B: GO:0004348, GO:0005764, GO:0005975, GO:0006665, GO:0007040, GO:0016020, GO:0016787, GO:0016798 | ||||||||||||||
disease | Gaucher disease with cardiovascularcalcification Gaucher disease Graves disease,susceptibility to,3 Hydrops fetalis, in utero fetal death and neonatal distress are prominent features. Type 3 (subacute, neuronopathic) have central nervous manifestations. In most cases, nonimmune hydrops fetalis is present, it is associated with hepatosplenomegaly, ichthyosis, arthrogryposis, and facial dysmorphism. Gaucher disease has been classified into three phenotypes. The defect leads to accumulation of glucosylceramide within the cells of the reticuloendothelial system. Another classification is based on the absence (type 1) or presence and severity of primary cns involvement. Defects in gba are the cause of pseudo-gaucher disease [mim. 231005]. Type 1 (adult, nonneuronopathic) is characterized by hepatosplenomegaly (consequent anemia and thrombopenia), and bone involvement, but the central nervous system is not involved. It is a distinct form of type 2 gaucher disease, characterized by fetal onset. It manifests soon after birth, with death generally occurring before patients reach two years of age. Defects in gba are the cause of gaucher disease (gd) [mim. 230800, 230900, 231000], the most prevalent lysosomal storage disease. Hepatosplenomegaly is a major sign, and is associated with ichthyosis, arthrogryposis, and facial dysmorphism in 35 to 43% of cases. Type 2 (acute neuronopathic), is the most severe form and is universally progressive and fatal. When hydrops is absent, neurologic involvement begins in the first week and leads to death within 3 months. Defects in gba are the cause of perinatal lethal gaucher disease [mim. 608013]. | ||||||||||||||
Primary reference | X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease., Dvir H, Harel M, McCarthy AA, Toker L, Silman I, Futerman AH, Sussman JL, EMBO Rep 2003 Jul;4(7):704-9. PMID:12792654 |
Data retrieval |
View 1OGS in 3D |
|
Visual 3D analysis of 1OGS |
|
Structure-derived information |
- Domain d1ogsa1, region A:1-77,A:432-497 [Jmol] [rasmolscript] [script source] - Domain d1ogsa2, region A:78-431 [Jmol] [rasmolscript] [script source] - Domain d1ogsb1, region B:1-77,B:432-497 [Jmol] [rasmolscript] [script source] - Domain d1ogsb2, region B:78-431 [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1OGS |
Movements, Movies and Images |